Resistance to hormonal treatment has been associated with mutations in members of the phosphatidylinositol-3-kinase (PI3K) family, which are present in up to nearly 40% of breast cancers and correlate with worse prognosis [4]. This evidence concerns the gene PIK3CA and breast carcinoma.